Each month, this report provides insight into how the behaviors and attitudes of GLP-1 (e.g., Ozempic, Wegovy, etc.) users are transforming and how theyre impacting a range of industries from healthcare to retail, food service, fitness, apparel, and even travel
People still eat, still enjoy food, but feel less controlled by random urgesespecially sweet cravings or late-night grazing
Yet many women who begin GLP-1 medications like Ozempic, Wegovy, or others notice something unexpected long before they reach their goals: the face starts to change
Unabsorbed L-carnitine is degraded by micro-organisms in the large intestine
Introducing Mounjaro: a dual-action approach Mounjaro (tirzepatide) activates both GIP and GLP-1 receptors
Hajialilo M